Aura Biosciences, Inc. (AURA) Misses Q2 EPS by 7c

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q2 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Aura Biosciences (AURA) PT Lowered to $18 at H.C. Wainwright
• Londian Wason New Energy Tech opens at $26, above IPO price of $22
• Spectrum and Optimum strike deal to restore and expand local news